The UK contact information of release dated Jan. 16, 2013, should read: Chempetitive Group Europe, Clare Russell, Tel +44 1223 421 304, crussell@chempetitive.com . , a development stage biotechnology company, today announced the award of a US$3.3 million contract from the US Defense Threat Reduction Agency to develop biodefence vaccine adjuvants ... (more)
http://www.freshnews.com/news/749547/correcting-and-replacing-dtra-awards-us-3-3m-contract-psioxus-therapeutics-develop-biod
http://www.freshnews.com/news/749547/correcting-and-replacing-dtra-awards-us-3-3m-contract-psioxus-therapeutics-develop-biod
No comments:
Post a Comment